{
    "2021-03-23": [
        [
            {
                "time": "",
                "original_text": "甘李药业GZR18临床试验申请获受理 GLP-1受体激动剂国内市场空间巨大",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "GZR18",
                        "临床试验",
                        "GLP-1受体激动剂",
                        "国内市场空间"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业(603087.SH)：GZR18临床试验申请获受理",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "GZR18",
                        "临床试验",
                        "受理"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业(603087.SH)：I类新药GZR18临床试验申请获受理",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "I类新药",
                        "GZR18",
                        "临床试验",
                        "受理"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "创新药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "我国胰岛素发展分析",
                "features": {
                    "keywords": [
                        "胰岛素",
                        "发展分析"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}